Higher Facility Volume Linked With Better Radiation Outcomes for Head and Neck Cancers

Video

A study presented last month at ASTRO found that better radiation outcomes for head and neck cancer were associated with higher facility volume.

A study presented last month at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Boston found that better radiation outcomes for head and neck cancer were associated with higher facility volume.

The findings revealed a 5.7% decreased hazard of death per additional 20 patients treated per facility each year. When annual facility case volume was defined based on a threshold of 95 cases/year (90th percentile), there was a 17.5% decreased hazard of death for higher-volume vs lower-volume facilities.

In this video, Henry S. Park, MD, MPH, of the Yale Cancer Center and Smilow Cancer Hospital in New Haven, Connecticut, discusses the results.

Related Videos
Treatment with toripalimab does not yield the same vascular toxicity seen with pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma, according to Barbara Burtness, MD.
Overall survival also appears to improve with toripalimab compared with chemotherapy among patients with metastatic or advanced nasopharyngeal carcinoma.
head and neck cancer
head and neck cancer
head and neck cancer
Related Content